IFCI Ltd. - Research Center
500106 IFCI Group (A) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 534.11 | 756.94 | 1,378.00 | 2,245.57 | 2,157.23 |
| Operating profit | 458.65 | -845.85 | -1,017.88 | 1,287.61 | 788.69 |
| Interest | 631.30 | 922.88 | 1,118.97 | 1,416.35 | 1,756.14 |
| Gross profit | -161.50 | -1,762.06 | -2,117.93 | -110.25 | -658.48 |
| EPS (Rs) | -1.31 | -9.47 | -10.33 | -1.64 | -2.62 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 11.15 | 6.67 | 18.92 | 18.49 | 308.97 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 99.27 | 92.43 | 91.09 | 143.92 | 112.12 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 55.48 | 137.04 | 33.16 | 1,119.16 | 1,256.42 |
| Provisions made | -79.29 | 1,373.32 | 2,271.63 | -305.12 | - |
| Depreciation | 24.07 | 23.03 | 29.30 | 30.66 | 32.81 |
| Taxation | 102.01 | 206.24 | -189.42 | 136.97 | -247.46 |
| Net profit / loss | -287.58 | -1,991.33 | -1,957.81 | -277.88 | -443.83 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 2,195.93 | 2,102.99 | 1,895.99 | 1,695.99 | 1,695.99 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 85.87 | -111.75 | -73.87 | 57.34 | 36.56 |
| GPM (%) | -29.62 | -230.75 | -151.61 | -4.87 | -26.70 |
| NPM (%) | -52.74 | -260.78 | -140.15 | -12.27 | -18.00 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis